Pamela D. Garzone

Dr. Garzone is a respected pharmaceutical executive with over 25 years of diverse experience in the industry and a significant record of achievement in drug development and leadership. During her career, she has successfully overseen the clinical development of dozens of assets driving their advancement through the clinic. She is currently the chief development officer of Anixa Biosciences, where she oversees a portfolio in oncology. Prior to joining Anixa, Dr. Garzone held executive roles in clinical development with several companies, including Calibr, a division of the Scripps Research Institute, and Pfizer. She previously held positions of increasing responsibility at companies such as Elan Pharmaceuticals and Genetics Institute, starting her industry career at Genentech. Prior to her industry experience, she was an Assistant Professor, Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. Dr. Garzone earned a B.S. degree in Pharmacy from Purdue University and an M.S. in Pharmacy Practice from the University of Pittsburgh. She received her Ph.D. in Clinical Science from the University of Pittsburgh.